2. Summary of quality.
Study |
Inclusion criteria similar for IPD‐MA and AD‐MA? |
Study quality* |
Comparison of IPD‐MA and AD‐MA a main aim of the study? |
IPD‐MA and AD‐MA done by independent researchers? |
Same outcome definitions for IPD‐MA and AD‐MA? |
Berlin 2002 | Yes | A | Yes | No | Yes |
Best 2000 | Yes | A | Yes | No | Yes |
Beveridge 2015 | Yes | A | No | No | Yes |
Brouwer 2009 | Yes | B (Insufficient information) | No | No | Yes |
Clarke 1998 | Yes | A | Yes | No | Yes |
D'Amico 1998 | Yes | A | Yes | No | Yes |
Duchateau 2001 | Yes | A | Yes | No | Yes |
Fortin 1995 | Yes | A | Yes | No | Yes |
Franzosi 1997 | Unclear | B (Insufficient information) | Yes | Unclear | Unclear |
Ioannidis 1999 | Yes | A | No | Yes | Yes |
Jeng 1995 | Yes | A | Yes | No | Yes |
Jones 2009 | Yes | A | Yes | No | Yes |
Kim 2010 | Yes | A | No | No | Yes |
Koopman 2008 | Yes | A | Yes | Yes | Yes |
le Chevalier 1996 | Yes | B (Statistical methods unclear) | Yes | Yes | Yes |
Legg 2003 | Unclear | B (Insufficient information) | Yes | Yes | Unclear |
Lindley 2005 | Yes | A | No | No | Yes |
Lukka 2006 | Yes | B (Statistical methods unclear) | No | Yes | Yes |
Michiels 2005 | Yes | A | Yes | No | Yes |
Myeloma 1998 | Yes | A | No | Unclear | Yes |
Pignon 1992 | Yes | A | Yes | Yes | Yes |
Rejnmark 2012 | Yes | A | No | Yes | Yes |
Rothwell 2011 | Yes | A | No | No | Yes |
Saillourglenisson 2000 | Yes | A | No | No | Yes |
Schmid 2004 | Yes | A | Yes | No | Yes |
Shepperd 2009 | Yes | A | No | No | Yes |
Spooner 1998 | Yes | B (Insufficient information) | Yes | Yes | Yes |
Stewart 1993 | Yes | A | Yes | Unclear | Yes |
Szczech 1998 | Yes | A | No | No | Yes |
Teramukai 2004 | Yes | A | Yes | No | Yes |
Thompson 2001 | Yes | A | Yes | Yes | Yes |
Tierney 2001 | Yes | B (Insufficient information) | Yes | Yes | Yes |
Tonia 2011 | No | B (Insufficient information) | No | Yes | No |
Tudur 2001 | Yes | A | No | No | Yes |
Tudur Smith 2005 | Yes | A | Yes | No | Yes |
Turner 2000 | Yes | A | Yes | No | Yes |
Vansteenkiste 2012 | Yes | B (Insufficient information) | No | No | Yes |
Walwyn 2015 | Yes | B (Insufficient information) | No | No | Yes |
Williamson 2000 | Yes | A | No | Yes | Yes |
* A = No important flaws; B = Possibly important flaws; C = Major flaws
Abbreviations: AD: Aggregate data, AD‐MA: Aggregate data meta‐analysis, IPD: Individual participant data, IPD‐MA: Individual participant data meta‐analysis